The effectiveness of the use of nitroglycerin for the correction of arterial hypertension in ophthalmic surgery: a single-center prospective study.

Objectives. To compare the effectiveness of hypotensive therapy with nitroglycerin, magnesium sulfate and droperidol during ophthalmic surgery. Materials and methods. 261 patients participated in the study.

The patients were randomized into 3 groups. Exclusion criteria: angle-closure glaucoma. Patients with an average blood pressure above 113 mm Hg underwent hypotensive therapy: group 1 Nitroglycerin (1-2 doses under the tongue); group 2 intravenously magnesium sulfate (5 ml 250 mg/ml); group 3 intravenously 1.0 ml droperidol (2.5 mg/ ml).

The effectiveness of antihypertensive therapy was assessed by the level of mean blood pressure (cf. BP) and heart rate (HR) during and after surgery, as well as the dynamics of IOP after surgery. Results.

After hypotensive therapy with nitroglycerin, blood pressure was lower compared to other groups during surgery (p≤0.005) and after (p=0.0004). Heart rate was significantly lower in the droperidol group (p<0.05). There was a tendency to a slight increase in IOP in patients in the nitroglycerin group.

However, there was no significant difference between the IOP values of OD (p=0.065) and OS (p=0.269). Conclusion(s). The use of nitroglycerin in the form of a spray (1-2 doses) quickly and effectively allows you to stabilize a high blood pressure level during ophthalmic surgery (except for patients with angle-closure glaucoma) can serve as a prevention of acute coronary syndrome.

In our study, nitroglycerin did not have a negative effect on the hydrodynamics of the eye. IOP before and after surgery remained at a stable level.